Updated PREDICT tool for breast cancer prognostication outperforms existing model
The PREDICT prognostication and treatment tool was developed in 2010 to help guide decisions for patients with invasive early-stage breast cancer. […]
Read MoreThe PREDICT prognostication and treatment tool was developed in 2010 to help guide decisions for patients with invasive early-stage breast cancer. […]
Read MoreWhilst appropriate focus has been on the US FDA approving 55 new drugs for 2023, of which 20 are first-in-class, […]
Read MoreThe antibody-drug conjugate ifinatamab deruxtecan demonstrated “robust and durable efficacy” in patients with heavily pretreated small cell lung cancer, according […]
Read MoreThe results from the eye-wateringly huge whole-genome sequencing (WGS) project on 13,880 tumors are finally published in this month’s Nature […]
Read MoreA new blood test developed by scientists and clinicians is able to detect the presence of prostate cancer and confirm how advanced it is.
Read MoreBreast cancer rates among women globally are on the rise, but new research is uncovering trends related to age and where you live that could help target prevention measures to improve the situation.
Read MoreA method known as CAR-T therapy has been used successfully in patients with blood cancers such as lymphoma and leukaemia. […]
Read MoreCancer cases have been rising over the years and according to the statistics, the number of people living with cancer […]
Read MoreA study led by the Institut de Neurociències (INc-UAB) describes a new strategy to tackle cancer, based on inducing a potent stress in tumour causing cell destruction by autophagy.
Read MoreA study published in American Journal of Respiratory and Critical Care Medicine indicates that an artificial intelligence strategy can correctly assess and categorise these indeterminate pulmonary nodules (IPNs).
Read MoreError: Contact form not found.